Evidence map›Paper›PMID 42136213›Full record

ReviewAnti-inflammatory & anti-allergy agents in medicinal chemistry2026

Synthesis and Biological Activity of Guanidine Scaffold: A Comprehensive Review.

Surendra Kumar Verma, Shweta Singh Verma, Amit Verma, Manshi Saxsena, Ajay Kumar, Vishnu Dev Verma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Surendra Kumar VermaSchool of Pharmaceutical Sciences, CSJM University, Kanpur, India.ORCID 0009-0002-8560-3419
Shweta Singh VermaSchool of Pharmaceutical Sciences, CSJM University, Kanpur, India.ORCID 0009-0007-8463-9782
Amit VermaPharmacy Department, Amity University Bengaluru, India.ORCID 0000-0003-1680-0363
Manshi SaxsenaSchool of Pharmaceutical Sciences, CSJM University, Kanpur, India.ORCID 0009-0007-0259-0605
Ajay KumarSchool of Pharmaceutical Sciences, CSJM University, Kanpur, India.ORCID 0009-0004-8915-8716
Vishnu Dev VermaSchool of Pharmaceutical Sciences, CSJM University, Kanpur, India.ORCID 0009-0000-9052-9140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Derivatives of guanidine are found to be highly informative for their design in antibacterial and anticancer applications, thus positioning them as promising future drug candidates. This study evaluates and synthesizes a diverse group of guanidine derivatives, with a focus on those bearing cyclic aryl and acyl groups. The prepared compounds showed strong antifungal and antibacterial activities with selectivity against Candida albicans and Gram-positive bacteria. The Structure-Activity Relationship analysis showed that substituent groups are important for biological activity, and n-propyl linkages achieved an optimal balance between hemolytic and antibacterial properties. Additionally, the antiproliferative activities of all synthesized compounds (110a-110v) were assessed in Michigan Cancer Foundation-7 (MCF-7) human breast cancer cells. The Structure Activity Relationship study results suggest that planned substitutions can significantly enhance biological activity, offering potential approaches to counter the growing threat of antibiotic resistance.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsGuanidineCandida albicansCell ProliferationGram-Positive BacteriaHumansMCF-7 CellsMicrobial Sensitivity TestsStructure-Activity RelationshipAnti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsGuanidineantibacterialanticancerantimicrobialCandida albicanscyclic/aryl guanidineMCF-7 cellsUrea/thiourea

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.